YAP1-V5 in pLX304 Citations (11)
Originally described in: beta-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis.Rosenbluh J, Nijhawan D, Cox AG, Li X, Neal JT, Schafer EJ, Zack TI, Wang X, Tsherniak A, Schinzel AC, Shao DD, Schumacher SE, Weir BA, Vazquez F, Cowley GS, Root DE, Mesirov JP, Beroukhim R, Kuo CJ, Goessling W, Hahn WC Cell. 2012 Dec 21;151(7):1457-73. doi: 10.1016/j.cell.2012.11.026. Epub 2012 Dec 13. PubMed Journal
Articles Citing YAP1-V5 in pLX304
| Articles |
|---|
| Transcriptional cofactor Mask2 is required for YAP-induced cell growth and migration in bladder cancer cell. Dong L, Lin F, Wu W, Huang W, Cai Z. J Cancer. 2016 Oct 23;7(14):2132-2138. eCollection 2016. PubMed |
| YAP1-Mediated Suppression of USP31 Enhances NFkappaB Activity to Promote Sarcomagenesis. Ye S, Lawlor MA, Rivera-Reyes A, Egolf S, Chor S, Pak K, Ciotti GE, Lee AC, Marino GE, Shah J, Niedzwicki D, Weber K, Park PMC, Alam MZ, Grazioli A, Haldar M, Xu M, Perry JA, Qi J, Eisinger-Mathason TSK. Cancer Res. 2018 May 15;78(10):2705-2720. doi: 10.1158/0008-5472.CAN-17-4052. Epub 2018 Feb 28. PubMed |
| Verteporfin inhibits YAP-induced bladder cancer cell growth and invasion via Hippo signaling pathway. Dong L, Lin F, Wu W, Liu Y, Huang W. Int J Med Sci. 2018 Apr 3;15(6):645-652. doi: 10.7150/ijms.23460. eCollection 2018. PubMed |
| Myt1 and Myt1l transcription factors limit proliferation in GBM cells by repressing YAP1 expression. Melhuish TA, Kowalczyk I, Manukyan A, Zhang Y, Shah A, Abounader R, Wotton D. Biochim Biophys Acta Gene Regul Mech. 2018 Nov;1861(11):983-995. doi: 10.1016/j.bbagrm.2018.10.005. Epub 2018 Oct 10. PubMed |
| The mitochondrial deoxyguanosine kinase is required for cancer cell stemness in lung adenocarcinoma. Lin S, Huang C, Sun J, Bollt O, Wang X, Martine E, Kang J, Taylor MD, Fang B, Singh PK, Koomen J, Hao J, Yang S. EMBO Mol Med. 2019 Oct 21:e10849. doi: 10.15252/emmm.201910849. PubMed |
| Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma. Shih DJH, Nayyar N, Bihun I, Dagogo-Jack I, Gill CM, Aquilanti E, Bertalan M, Kaplan A, D'Andrea MR, Chukwueke U, Ippen FM, Alvarez-Breckenridge C, Camarda ND, Lastrapes M, McCabe D, Kuter B, Kaufman B, Strickland MR, Martinez-Gutierrez JC, Nagabhushan D, De Sauvage M, White MD, Castro BA, Hoang K, Kaneb A, Batchelor ED, Paek SH, Park SH, Martinez-Lage M, Berghoff AS, Merrill P, Gerstner ER, Batchelor TT, Frosch MP, Frazier RP, Borger DR, Iafrate AJ, Johnson BE, Santagata S, Preusser M, Cahill DP, Carter SL, Brastianos PK. Nat Genet. 2020 Apr;52(4):371-377. doi: 10.1038/s41588-020-0592-7. Epub 2020 Mar 23. PubMed |
| YAP1 regulates chondrogenic differentiation of ATDC5 promoted by temporary TNF-alpha stimulation through AMPK signaling pathway. Chen P, Yang B, Wu Y, Wang J. Mol Cell Biochem. 2020 Nov;474(1-2):209-218. doi: 10.1007/s11010-020-03846-z. Epub 2020 Aug 3. PubMed |
| Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer. Liu M, Zhang Y, Yang J, Zhan H, Zhou Z, Jiang Y, Shi X, Fan X, Zhang J, Luo W, Fung KA, Xu C, Bronze MS, Houchen CW, Li M. Gastroenterology. 2021 Apr;160(5):1771-1783.e1. doi: 10.1053/j.gastro.2020.12.077. Epub 2021 Jan 6. PubMed |
| Disruption of pancreatic stellate cell myofibroblast phenotype promotes pancreatic tumor invasion. Murray ER, Menezes S, Henry JC, Williams JL, Alba-Castellon L, Baskaran P, Quetier I, Desai A, Marshall JJT, Rosewell I, Tatari M, Rajeeve V, Khan F, Wang J, Kotantaki P, Tyler EJ, Singh N, Reader CS, Carter EP, Hodivala-Dilke K, Grose RP, Kocher HM, Gavara N, Pearce O, Cutillas P, Marshall JF, Cameron AJM. Cell Rep. 2022 Jan 25;38(4):110227. doi: 10.1016/j.celrep.2021.110227. PubMed |
TEAD Inhibition Overcomes YAP1/TAZ-driven Primary and Acquired Resistance to KRASG12C Inhibitors.
Edwards AC, Stalnecker CA, Jean Morales A, Taylor KE, Klomp JE, Klomp JA, Waters AM, Sudhakar N, Hallin J, Tang TT, Olson P, Post L, Christensen JG, Cox AD, Der CJ.
Cancer Res. 2023 Nov 7. doi: 10.1158/0008-5472.CAN-23-2994.
PubMed
Associated Plasmids |
| Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells. Rio-Vilarino A, Cenigaonandia-Campillo A, Garcia-Bautista A, Mateos-Gomez PA, Schlaepfer MI, Del Puerto-Nevado L, Aguilera O, Garcia-Garcia L, Galeano C, de Miguel I, Serrano-Lopez J, Banos N, Fernandez-Acenero MJ, Lacal JC, Medico E, Garcia-Foncillas J, Cebrian A. Br J Cancer. 2024 May;130(8):1402-1413. doi: 10.1038/s41416-024-02649-z. Epub 2024 Mar 11. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.